[Pj-018B] Japanese Poster Session 018B　Neuroimmunology (NMO 1)

[Pj-018B-6] Survey on Inebilizumab Use for NMOSD (5th interim analysis): Safety and Effectiveness

Kazuo Fujihara^1,2, Shinya Hirota³, Hideki Aya³, Hideaki Hida³, Muneyoshi Kudo³, Satoshi Yuki³, Kyoko Kato³ (1.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University, Japan, 2.Multiple Sclerosis and Neuromyelitis Optica Center, Southern Tohoku Research Institute for Neuroscience, Japan, 3.Mitsubishi Tanabe Pharma Corporation, Japan)

Password required to view